GSK initiates phase III trials of GSK-3196165 in moderate to severely active rheumatoid arthritis June 20, 2019
New phase I study evaluates TBX-3400 in stage III/IV melanoma resistant or refractory to immune CPIs June 20, 2019
Disulfiram and copper with concurrent RT and temozolomide for glioblastoma: phase I/II trial June 20, 2019
RSS